Investors - ALDA Pharmaceuticals Corp.

ALDA Pharmaceuticals Corp.

Company

Products

investors

Sales

Contact Us

Olympics | 2010 Vancouver Olympic Games Medals Results Schedule Sports

APH:TSX-V
Financials
News Releases

Contact Information

Shareholder, Broker & Analyst
Scott Young

TEL: (604) 521 - 8300 EXT.8
CEL: (604) 377 - 5781
E-mail: scott_young@aldacorp.com

2010 NEWS RELEASES

[ Click here for year 2009 ]

August 31st

New “Superbugs” could go global (89.458 kb PDF file)

July 30th

ALDA Pharmaceuticals to Undertake Revised Private Placement (91.803 kb PDF file)

June 4th

LETTER TO THE SHAREHOLDERS OF ALDA PHARMACEUTICALS CORP (79.053 kb PDF file)

April 16th

ALDA Pharmaceuticals Appoints Medical Director (57.775 kb PDF file)

April 15th

ALDA Pharmaceuticals Undertakes Private Placement (75.582 kb PDF file)

April 7th

ALDA receives FDA permission to sell products in the US (72.732 kb PDF file)

March 2nd

ALDA receives Australian Patent for T36® Disinfectant (57.276 kb PDF file)

February 5th

ALDA Pharmaceuticals Corp. named as part of 2010 TSX Venture 50 (82.549 kb PDF file)

January 19th

LETTER TO THE SHAREHOLDERS OF ALDA PHARMACEUTICALS CORP. (76.434 kb PDF file)

January 15th

ALDA AGM held on December 11, 2009 (47.741 kb PDF file)